Latest filing published 05 May 2022 for 三诺生物.
李心一: trading record in brief
李心一, listed as chief executive, appears in our data through filings on 三诺生物 shares, published by SSE / SZSE (CSRC). Between 8 November 2021 and 5 May 2022, the trades on record add up to 3 filings.
Purchases make up the whole of the open-market record (3 purchases, €1.3M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2022: 2 purchases and no sales on the market.
The median purchase comes to €21k. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 5 May 2022 with an open-market purchase (€21k) in 三诺生物. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 李心一
Open company profiles for insider transactions, fundamentals and analyst consensus when available.